Jul 27, 2021 9:53 AM
BACK TO TOP
KSE100
47,763.21
90.53
(0.19%)
ALLSHR
32,655.14
76.68
(0.24%)
KSE30
19,143.23
36.36
(0.19%)
KMI30
77,415.03
141.64
(0.18%)
BKTi
12,730.85
43.33
(0.34%)
OGTi
12,363.13
60.39
(0.49%)
KMIALLSHR
23,394.64
51.96
(0.22%)
UPP9
13,298.44
14.33
(0.11%)
NITPGI
9,793.73
17.43
(0.18%)
NBPPGI
11,852.71
20.92
(0.18%)
MZNPI
11,257.16
5.88
(0.05%)
GlaxoSmithKline Consumer Healthcare
PHARMACEUTICALS
Rs.242.75
0.00
(0.00%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Tue, Jul 27, 2021 9:49 AM
REG
FUT
ODL
Open
242.75
High
242.75
Low
242.75
Volume
1,000
CIRCUIT BREAKER
224.54 — 260.96
DAY RANGE
242.75 — 242.75
52-WEEK RANGE
209.75 — 336.00
Ask Price
244.80
Ask Volume
1,000
Bid Price
242.75
Bid Volume
100
LDCP
242.75
VAR
13.50
HAIRCUT
25.00
P/E Ratio (TTM) **
18.03
1-Year Change *
-22.88%
YTD Change *
-8.44%
Open
240.11
High
240.11
Low
240.11
Close
240.11
Change
-1.17%
LDCP
0.00
Volume
10
Total Trades
1
CIRCUIT BREAKER
218.48 — 267.03
DAY RANGE
240.11 — 240.11
Ask Price
259.40
Ask Volume
19
Bid Price
240.00
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on March 31, 2015 principally to effect the demerger of consumer healthcare business of GlaxoSmithKline Pakistan Limited (GSK Pakistan). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is GlaxoSmithKline plc, UK. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.

KEY PEOPLE
Mr. Farhan Muhammad HaroonCEO
Mr. M.Z. Moin MohajirChairman
Ms. Mashal MohammadCompany Secretary
ADDRESS

35 – Dockyard Road, West Wharf, Karachi – 74000

WEBSITE

www.pk-consumerhealthcare.gsk.com

REGISTRAR

CDC Share Registrar Services Limited

AUDITOR

Yousuf Adil and Co., Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
28,414,981.82
Shares
117,054,508
Free Float
15,554,587
Free Float
13.29%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 29, 2021Transmission of Quarterly Report for the Period Ended 31 March 2021 View   PDF
Apr 23, 2021Financial Results for the Quarter Ended 2021-03-31 View   PDF
Mar 31, 2021Transmission of Annual Report for the Year Ended 2020 View   PDF
Mar 5, 2021Financial Results for the Year Ended December 31, 2020 View   PDF
Oct 29, 2020Transmission of Quarterly Report for the Period Ended 30 September 2020 View   PDF
Oct 27, 2020Financial Results for the Quarter Ended 2020-09-30 View   PDF
Aug 31, 2020Transmission of Quarterly Report for the Period Ended 30-06-2020 View   PDF
Aug 28, 2020Transmission of Quarterly Report for the Period Ended 30-06-2020
REVOKED
View   PDF
Aug 26, 2020Financial Results for the Quarter Ended - 2020-06-30 View   PDF
Apr 29, 2020AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DEC 2019 View   PDF
DateTitleDocument
Apr 22, 2021Resolution passed by the Shareholders in the Annual General Meeting. View   PDF
Apr 16, 2021Notice of Board Meeting (Q1-2021) View   PDF
Mar 31, 2021Notice of Annual General Meeting View   PDF
Mar 1, 2021Board Meeting - Q4-2020 View   PDF
Oct 20, 2020Board Meeting View   PDF
Aug 19, 2020Board Meeting View   PDF
May 13, 2020Board Meeting Notice & Closed Period View   PDF
Apr 29, 2020NOTICE OF ANNUAL GENERAL MEETING 2019 View   PDF
Mar 25, 2020GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited - Postponement of Annual General Meeting PDF
Mar 6, 2020Board Meeting View   PDF
DateTitleDocument
May 5, 2021Credit of Final Cash Dividend - YE 31 Dec 2020 View   PDF
May 4, 2021Prior Publication of Dividend Notice View   PDF
Apr 30, 2021GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited PDF
Apr 1, 2021Change of Chief Executive Officer View   PDF
Mar 30, 2021Prior Publication of AGM Notice View   PDF
Mar 30, 2021Prior Publication of AGM Notice
REVOKED
View   PDF
Mar 25, 2021Revised Book Closure View   PDF
Mar 4, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Mar 3, 2021Appointment of Non-Executive Independent Director View   PDF
Feb 8, 2021Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2020201920182017
Sales19,846,10616,316,74514,875,2688,298,142
Profit after Taxation1,262,0091,257,5191,074,553706,815
EPS10.7810.749.187.39
Q1 2021Q3 2020Q2 2020Q1 2020
Sales5,234,8285,281,0714,900,3274,308,055
Profit after Taxation615,009295,959382,937300,661
EPS5.252.533.272.57
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2020201920182017
Gross Profit Margin (%)26.8530.5629.1837.37
Net Profit Margin (%)6.367.717.228.52
EPS Growth (%)0.3716.9924.22(2.76)
PEG66.041.401.20(15.75)

Payouts

DateFinancial ResultsDetailsBook Closure
March 5, 2021 5:21 PM31/12/2020(YR) 50%(F) (D) 17/04/2021 - 21/04/2021
March 12, 2020 6:23 PM31/12/2019(YR) 50%(F) (D) 14/05/2020 - 20/05/2020
March 18, 2019 5:17 PM31/12/2018(YR) 50%(F) (D) 18/04/2019 - 23/04/2019
January 29, 2018 3:23 PM31/12/2017(YR) 50% (D) 23/03/2018 - 29/03/2018

Financial Reports